Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure

BACKGROUND: Sodium-glucose cotransporter 2 inhibitor (SGLT2i) reduces the risk of the composite renal endpoint and weakens the progressive decline in renal function in patients with chronic heart failure (HF). However, a detailed mechanism of SGLT2i on renal function and outcome remains uninvestigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagaito, Masaki, Imamura, Teruhiko, Joho, Shuji, Ushijima, Ryuichi, Nakamura, Makiko, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296582/
https://www.ncbi.nlm.nih.gov/pubmed/34289813
http://dx.doi.org/10.1186/s12872-021-02163-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296582/
https://www.ncbi.nlm.nih.gov/pubmed/34289813
http://dx.doi.org/10.1186/s12872-021-02163-7

Ejemplares similares